本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Kymera Therapeutics, Inc.

45.51
+0.60001.34%
成交量:50.71萬
成交額:2,308.29萬
市值:31.93億
市盈率:-14.62
高:46.00
開:45.21
低:44.89
收:44.91
資料載入中...
2024/03/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/22

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/22

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/11

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]